| Primary |
| Product Used For Unknown Indication |
32.0% |
| Antiplatelet Therapy |
11.0% |
| Prophylaxis |
11.0% |
| Cerebrovascular Accident |
5.0% |
| Hypertension |
5.0% |
| Ischaemic Stroke |
5.0% |
| Cardiac Disorder |
4.0% |
| Atrial Fibrillation |
3.0% |
| Diabetes Mellitus |
3.0% |
| Myocardial Ischaemia |
3.0% |
| Anaemia |
2.0% |
| Angioplasty |
2.0% |
| Bipolar Disorder |
2.0% |
| Cardiovascular Event Prophylaxis |
2.0% |
| Colitis Ulcerative |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Platelet Aggregation Inhibition |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Bronchopneumonia |
1.0% |
| Carotid Artery Disease |
1.0% |
|
| Thrombotic Microangiopathy |
25.6% |
| Subdural Haematoma |
20.5% |
| Melaena |
5.1% |
| Presyncope |
5.1% |
| Sepsis |
5.1% |
| Subendocardial Ischaemia |
5.1% |
| Anaemia |
2.6% |
| Chest Pain |
2.6% |
| Depressed Level Of Consciousness |
2.6% |
| Erythropoiesis Abnormal |
2.6% |
| Eyelid Oedema |
2.6% |
| Haemorrhagic Infarction |
2.6% |
| Hepatitis Cholestatic |
2.6% |
| Hypertensive Crisis |
2.6% |
| Implant Site Haematoma |
2.6% |
| International Normalised Ratio Increased |
2.6% |
| Polyp |
2.6% |
| Tachycardia |
2.6% |
| Weight Decreased |
2.6% |
|
| Secondary |
| Myocardial Infarction |
16.7% |
| Acute Myocardial Infarction |
15.9% |
| Percutaneous Coronary Intervention |
13.6% |
| Anticoagulant Therapy |
9.1% |
| Product Used For Unknown Indication |
7.6% |
| Coronary Arterial Stent Insertion |
6.8% |
| Antiplatelet Therapy |
5.3% |
| Hypertension |
3.8% |
| Diabetes Mellitus |
3.0% |
| Prophylaxis |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Acute Coronary Syndrome |
1.5% |
| Anaesthesia |
1.5% |
| Basilar Artery Occlusion |
1.5% |
| Brain Stem Haemorrhage |
1.5% |
| Cardiopulmonary Bypass |
1.5% |
| Intra-aortic Balloon Placement |
1.5% |
| Ischaemic Stroke |
1.5% |
| Myocardial Ischaemia |
1.5% |
| Premedication |
1.5% |
|
| Death |
11.4% |
| Procedural Haemorrhage |
8.6% |
| Thrombosis In Device |
8.6% |
| Gynaecomastia |
5.7% |
| Pemphigoid |
5.7% |
| Refractory Cytopenia With Unilineage Dysplasia |
5.7% |
| Renal Failure Acute |
5.7% |
| Retroperitoneal Haematoma |
5.7% |
| Toxic Skin Eruption |
5.7% |
| Traumatic Liver Injury |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Agranulocytosis |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.9% |
| Haemorrhage |
2.9% |
| Melaena |
2.9% |
| Myocardial Infarction |
2.9% |
| Nausea |
2.9% |
| Oedema |
2.9% |
| Product Substitution Issue |
2.9% |
| Screaming |
2.9% |
|
| Concomitant |
| Acute Myocardial Infarction |
29.5% |
| Product Used For Unknown Indication |
16.0% |
| Myocardial Infarction |
13.1% |
| Hypertension |
7.1% |
| Percutaneous Coronary Intervention |
5.4% |
| Colitis Ulcerative |
3.2% |
| Diabetes Mellitus |
2.6% |
| Immunosuppression |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Benign Prostatic Hyperplasia |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Prophylaxis |
1.9% |
| Bronchitis |
1.6% |
| Cardiac Failure |
1.6% |
| Convulsion |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Insomnia |
1.6% |
| Cardiovascular Disorder |
1.3% |
|
| Coronary Artery Stenosis |
9.8% |
| Intracardiac Thrombus |
9.8% |
| Rectal Haemorrhage |
5.9% |
| Renal Impairment |
5.9% |
| Therapeutic Response Decreased |
5.9% |
| Thrombosis In Device |
5.9% |
| Ventricular Hypertrophy |
5.9% |
| Bronchitis |
3.9% |
| Cardiac Death |
3.9% |
| Coronary Artery Disease |
3.9% |
| Death |
3.9% |
| Hypotension |
3.9% |
| Ischaemia |
3.9% |
| Malaise |
3.9% |
| Osteonecrosis Of Jaw |
3.9% |
| Proctalgia |
3.9% |
| Pruritus |
3.9% |
| Renal Failure Acute |
3.9% |
| Transaminases Increased |
3.9% |
| Tremor |
3.9% |
|
| Interacting |
| Hypertension |
16.7% |
| Myocardial Ischaemia |
16.7% |
| Pain |
16.7% |
| Peripheral Ischaemia |
16.7% |
| Thrombosis Prophylaxis |
16.7% |
| Ulcer |
16.7% |
|
| Anaemia |
50.0% |
| Epistaxis |
50.0% |
|
